PureTech Health PLC banner

PureTech Health PLC
OTC:PRTCY

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
OTC:PRTCY
Watchlist
Price: 18.2 USD -1.65%
Market Cap: $4.4B

Wall St Price Targets

PRTCY Price Targets Summary
PureTech Health PLC

Wall Street analysts forecast PRTCY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTCY is 72.54 USD with a low forecast of 71.83 USD and a high forecast of 74.68 USD.

Lowest Forecast
Price Target
71.83 USD
295% Upside
Average Forecast
Price Target
72.54 USD
299% Upside
Highest Forecast
Price Target
74.68 USD
310% Upside
PureTech Health PLC Competitors:
Price Targets
PGEN
Precigen Inc
135% Upside
MDLZ
Mondelez International Inc
11% Upside
NYXH
Nyxoah SA
247% Upside
CENT
Central Garden & Pet Co
29% Upside
BTBT
Bit Digital Inc
161% Upside

Revenue
Forecast

-5% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
38%
Average Beat
-5% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
38%
Average Beat

Over the last 11 years, the compound annual growth rate for Revenue has been -5%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PRTCY's stock price target?
Price Target
72.54 USD

According to Wall Street analysts, the average 1-year price target for PRTCY is 72.54 USD with a low forecast of 71.83 USD and a high forecast of 74.68 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett